Literature DB >> 21229292

Sensitization to TRAIL-induced apoptosis in human neuroblastoma SK-N-AS cells by NF-κB inhibitors is dependent on reactive oxygen species (ROS).

Tom Gatsinzi1, Kerstin Iverfeldt.   

Abstract

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has been shown to induce apoptosis in a variety of cancer cell lines with almost no toxicity toward normal cells. However, many neuroblastoma cells acquire resistance to TRAIL by mechanisms that are poorly understood. The objective of this study was to investigate involvement of the transcription factor NF-κB in the resistance of human neuroblastoma SK-N-AS cells to TRAIL-induced apoptosis. We used five compounds previously reported to inhibit NF-κB activity. SN50, curcumin, oridonin, and pyrrolidine dithiocarbamate (PDTC) all sensitized cells to TRAIL-induced apoptosis. In contrast, N-alpha-tosyl-L: -phenylalanyl chloromethyl ketone (TPCK) did not affect sensitivity to TRAIL, although reporter gene assay clearly showed inhibition of NF-κB activity. In addition, neither curcumin nor oridonin had any inhibitory effect on NF-κB activity at concentrations at which sensitization to TRAIL was observed. Instead, the free radical scavenger N-acetyl-L: -cysteine (NAC) completely blocked the effect on TRAIL-induced apoptosis caused by curcumin, oridonin, and PDTC. Furthermore, exposure of SK-N-AS cells to H(2)O(2) could mimic the TRAIL-sensitizing effect of other agents. In conclusion, our results suggest that sensitization of neuroblastoma SK-N-AS cells to TRAIL-induced apoptosis is correlated with induction of reactive oxygen species (ROS) rather than inhibition of NF-κB.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21229292     DOI: 10.1007/s11060-010-0516-y

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  49 in total

Review 1.  Nuclear factor-kappaB in cancer development and progression.

Authors:  Michael Karin
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

2.  Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages.

Authors:  V Ciccarone; B A Spengler; M B Meyers; J L Biedler; R A Ross
Journal:  Cancer Res       Date:  1989-01-01       Impact factor: 12.701

3.  Inhibition of the NF-kappaB pathway enhances TRAIL-mediated apoptosis in neuroblastoma cells.

Authors:  Bahri Karacay; Salih Sanlioglu; Thomas S Griffith; Anthony Sandler; Daniel J Bonthius
Journal:  Cancer Gene Ther       Date:  2004-10       Impact factor: 5.987

Review 4.  Molecular basis of clinical heterogeneity in neuroblastoma.

Authors:  G M Brodeur; A Nakagawara
Journal:  Am J Pediatr Hematol Oncol       Date:  1992-05

5.  The mitogen-activated protein kinase pathway can inhibit TRAIL-induced apoptosis by prohibiting association of truncated Bid with mitochondria.

Authors:  G Ortiz-Ferrón; S W Tait; G Robledo; E de Vries; J Borst; A López-Rivas
Journal:  Cell Death Differ       Date:  2006-02-17       Impact factor: 15.828

Review 6.  Apoptotic pathways in tumor progression and therapy.

Authors:  Armelle Melet; Keli Song; Octavian Bucur; Zainab Jagani; Alexandra R Grassian; Roya Khosravi-Far
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

Review 7.  TRAIL in cancer therapy: present and future challenges.

Authors:  Delphine Mérino; Najoua Lalaoui; Alexandre Morizot; Eric Solary; Olivier Micheau
Journal:  Expert Opin Ther Targets       Date:  2007-10       Impact factor: 6.902

8.  Human neuroblastoma I-type cells are malignant neural crest stem cells.

Authors:  R A Ross; B A Spengler; C Domènech; M Porubcin; W J Rettig; J L Biedler
Journal:  Cell Growth Differ       Date:  1995-04

Review 9.  Tumor resistance to apoptosis.

Authors:  Simone Fulda
Journal:  Int J Cancer       Date:  2009-02-01       Impact factor: 7.396

10.  Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis.

Authors:  Sharmila Shankar; Suthakar Ganapathy; Qinghe Chen; Rakesh K Srivastava
Journal:  Mol Cancer       Date:  2008-01-29       Impact factor: 27.401

View more
  3 in total

1.  TRAIL resistance in human neuroblastoma SK-N-AS cells is dependent on protein kinase C and involves inhibition of caspase-3 proteolytic processing.

Authors:  Tom Gatsinzi; Elena V Ivanova; Kerstin Iverfeldt
Journal:  J Neurooncol       Date:  2012-07-15       Impact factor: 4.130

2.  NGF sensitizes TrkA SH-SY5Y neuroblastoma cells to TRAIL-induced apoptosis.

Authors:  P Ruggeri; L Cappabianca; A R Farina; L Gneo; A R Mackay
Journal:  Cell Death Discov       Date:  2016-02-01

3.  Oridonin induces Mdm2-p60 to promote p53-mediated apoptosis and cell cycle arrest in neuroblastoma.

Authors:  Han-Qing Zhu; Chao Zhang; Zhu-Ying Guo; Jun-Mei Yang; Jia-Hui Guo; Chen Chen; Qiang-Hua Yao; Feng Liu; Quan-Wu Zhang; Feng-Hou Gao
Journal:  Cancer Med       Date:  2019-07-24       Impact factor: 4.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.